Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Krishna Yeshwant Insider Profile
18 Followers
Krishna Yeshwant, Director at Foundation Medicine, holds 12.17M shares in Verve Therapeutics (Ticker: VERV), holds 0.00 shares in Foundation Medicine (Ticker: FMI), holds ― shares in EQRx, Inc. (Ticker: EQRX). Most recently, Krishna Yeshwant Bought ― shares of Verve Therapeutics on Dec 05, 2023 for an estimated value of 18.00M.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-48.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Krishna Yeshwant's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Krishna Yeshwant holds in companies
Most Profitable Insider Trade
Stock:
Foundation Medicine
(FMI)
(FMI)
Rating:Informative Sell
Date:May 18, 2015 - May 18, 2016
Return:+52.20%
The most profitable trade made by Krishna Yeshwant
Krishna Yeshwant's Trading History
Foundation Medicine
Aug 02, 2018
―
Uninformative Sell
792.68K
$0.00
Verve Therapeutics
Dec 05, 2023
Director, Ten Percent Owner
Informative Buy
18.00M
$72.28M
EQRx, Inc.
―
―
―
―
List of latest transactions for each holding click on a transaction to see Krishna Yeshwant's performance on stock
You May Also Like
Krishna Yeshwant insider profile FAQ
What is the percentage of profitable transactions made by Krishna Yeshwant?
The percentage of profitable transactions made by Krishna Yeshwant is 40%.
What is the average return per transaction made by Krishna Yeshwant?
The average return per transaction made by Krishna Yeshwant is -48.70%.
What stocks does Krishna Yeshwant hold?
Krishna Yeshwant holds: FMI, VERV, EQRX stocks.
What was Krishna Yeshwant’s latest transaction?
Krishna Yeshwant latest transaction was an Informative Buy of $18.00M.
What was Krishna Yeshwant's most profitable transaction?
Krishna Yeshwant’s most profitable transaction was an Informative Sell of FMI stock on May 18, 2015. The return on the trade was 52.20%.
What is Krishna Yeshwant's role in Foundation Medicine?
Krishna Yeshwant's role in Foundation Medicine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.